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ABSTRACT 
The current study aimed to determine the prevalence of Extended-Spectrum b-Lactamases 
(ESBLs) in Escherichia coli (E. coli) and Klebsiella pneumoniae (K. pneumoniae) strains 
isolated from patients with Urinary Tract Infections (UTIs), to study the association between 
presence of ESBL enzyme and multi-drug resistance strains and finally, and to investigate the 
predominant ESBL gene in E. coli and K. pneumoniae. The strains were examined for the 
presence of ESBL as a Clinical Laboratory Standards Institute (CLSI) guideline. Among 284 
clinical isolates, 52.8% (n = 150) and 47.2% (n =134) were E. coli and K. pneumoniae, 
respectively, and 110 strains were ESBL producer, which 68 strains were K. pneumoniae and 
42 strains were E. coli. Significant difference observed between the TEM gene and 
ciprofloxacin resistant in E. coli (P ? 0.05) while no significant difference observed between 
CTX-M, SHV genes and the other multi-drug resistant E. coli. No significant difference 
observed between CTX-M, TEM, and SHV genes and multi-drug resistant K. pneumoniae. In 
conclusion, spreading of ESBL-producing strains is a concern, as it causes limitations to the 
antimicrobial agents for optimal treatment of patients. Prevalence of ESBLs was more 
observed in K. pneumoniae than E. coli. In addition, TEM gene was more prevalent in E. coli 
and resistance to ciprofloxacin was predominant in E. coli. 
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